Abstract
Gentamicin intrapatient pharmacokinetics variations were studied in 40 critically ill medical patients, suffering gram-negative sepsis. These patients were studied in two phases throughout gentamicin treatment: firstly, on the second day of treatment, when aggressive fluid therapy was required, and secondly, five days later, when patients had achieved a more stable clinical condition. Pharmacokinetic parameters were determined using least squares linear regression analysis assuming a one-compartment model using the Sawchuk-Zaske method. The apparent volume of distribution (Vd) in the first phase of the study was 0.43±0.12 L/kg, while on the seventh day of treatment it was 0.29±0.17 L/kg (p<0.001). Statistically significant differences were also observed for peak serum concentration (p<0.001), total dosage recommended (p<0.001) and half-life (p<0.05), whilst differences were not found for trough levels. From the analysis of the results obtained, we recommend increasing the initial dosage and monitoring plasma levels within the first days of therapy in critically ill patients treated with gentamicin, since important variations in aminoglycoside Vd related to disease, fluid balance and renal function, commonly occur in these patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cunnion RE, Parrillo JE (1989) Miocardial dysfunction in sepsis. Recent insights. Chest 95:941–945
Reilly JM, Cunnion RE, Burch-Witman C, Parker M, Shelhamer JH, Parillo JE (1989) A circulatory myocardial depressant substance is associated with cardiac dysfunction and peripheral hypoperfusion (lactic acidemia) in patients with septic shock. Chest 95:1072–1080
Moore RD, Smith CR, Lietman PS (1984) The association of aminoglycoside plasma levels with mortality in patients with gramnegative bacteremia. J Infect Dis 149:443–448
Summer WR, Michael JR, Lisky JJ (1983) Initial aminoglycoside levels in critically ill. Crit Care Med 11:948–950
Zaske DE, Cipolle RJ, Rotschafter JC (1982) Gentamicin pharmacokinetics in 1640 patients: method for control of serum concentrations. Antimicrob Agents Chemother 21:407–411
Zaske DE, Cipolle RJ, Strate RJ (1980) Gentamicin dosage requirements: wide interpatient variations in 242 surgery patients with normal serum function. Surgery 87:64–69
Mann HJ, Fuhs DW, Awang R, Ndemo FA, Cerra FB (1988) Altered aminoglycoside pharmacokinetics in critically ill patients with sepsis. Clin Pharm 6:148–153
Fuhs DW, Mann HJ, Kubajak CA, Cerra FB (1987) Intrapatient variation of aminoglycoside pharmacokinetics in critically ill surgery patients. Clin Pharm 7:207–213
Triginer C, Fernández R, Izquierdo I, Benito S (1989) Gentamicin pharmacokinetic changes related to mechanical ventilation. Drug Intell Clin Pharm 23:923–924
Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM (1988) CDC definitions for nosocomial infections, 1988. Am J Infect Control 16:128–140
Schwartz SN, Pazin GJ, Lyon JA (1978) A controlled investigation of the pharmacokinetics of gentanicin and tobramicin in obese subjects. J Infect Dis 138:499–504
Sawchuk RJ, Zaske DE (1976) Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions. J Pharmacokinet Biopharm 4:183–195
Devine BJ (1974) Gentamicin therapy. Drug Intell Clin Pharm 8:650–655
Zaske DE, Cipolle RJ, Strate RG, Malo JW, Kozalka MS (1980) Rapid gentamicin elimination in obstetrical patients. Obstet Gynecol 56:559–564
Zaske DE, Sawchuk RJ, Gerding DN, Strate RG (1976) Increased dosage requirements of gentamicin in burn patients. J Trauma 16:824–828
Kaojarern S, Maoleekoonpairoj S, Atichartakarn V (1989) Pharmacokinetics of amikacin in hematologic malignancies. Antimicrob Agents Chemother 33:1406–1408
Carr MR, Dick SP, Bordley J, Bertino JB (1988) Gentamicin dosing requirements in patients with acute pancreatitis. Surgery 103:533–537
Schentag JJ, Jusko WJ, Vance JW (1977) Gentamicin disposition and tissue accumulation on multiple dosing. J Pharmacokinet Biopharm 5:559–577
King CH, Creger RJ, Ellner JJ (1985) Pharmacokinetics of tobramycin and gentamicin in abusers of intravenous drugs. Antimicrob Agents Chemother 27:285–290
Koup JR (1989) Disease states and drug pharmacokinetics. J Clin Pharmacol 29:674–679
Mackowiak PA (1989) Influence of fever on pharmacokinetics. Rev Infect Dis 5:804–807
Schentag JJ, Jusko WJ, Vance JW (1977) Gentamicin disposition and tissue accumulation on multiple dosing. J Pharmacokinet Biopharm 5:559–577
Nahata MC, Durrell DE, Miller MA (1986) Accuracy of tobramycin piggyback delivery using gravity flow versus controller. Am J Hosp Pharm 43:947–949
Armistead JA, Nahata MC (1983) Effect of variables associated with intermittent gentamicin infusion on pharmacokinetic predictions. Clin Pharm 2:153–156
Gingell JC, Chisholm GD, Colnan JS (1969) The volume of distribution and excretion of gentamicin with especial reference to renal failure. J Infect Dis 199:396–445
Gyselynck AM, Forrey A Cutler R (1971) Pharmacokinetics of gentamicin; distribution and plasma and renal clearance. J Infec Dis 124:70–76
Niemec PW, Allo MD, Miller CF (1987) Effect of altered volume of distribution on aminoglycoside levels in patients in surgical care. Arch Surg 122:207–211
Weaver RH, Cipolle RJ (1983) Improved aminoglycoside therapy: Clinical application of pharmacokinetic principles. In: Dennis Mungall (ed) Applied clinical pharmacokinetics. Raven Press, New York, pp 153–185
Needleman P, Greenwald JE (1986) Atriopeptin: a cardiac hormone intimately involved in fluid electrolyte, and blood pressure homeostasis. N Engl J Med 314:828–834
Farge D, Payen D (1989) Facteur natriurétique auriculaire (ANF). Aspects physiopathologiques. Réan Soins Intens Méd Urg 5:63–69
Skorecki KL, Leung WM, Campbell P, Warner LC, Wong PY, Bull S, Logan AG, Blendis LM (1988) Role of atrial natriuretic peptide in the natriuretic response to central volume expansion induced by heat-out water immersion in sodium retaining cirrhotic subjects. Am J Med 85:375–382
Winter RJD, Davidson AC, Treacher D, Rudd RM, Anderson JV, Meleagros L, Bloom SR (1989) Atrial natriuretic peptide concentrations in hypoxic secondary pulmonary hypertension: relation to haemodynamic and blood gas variables and response to supplemental oxygen. Thorax 44:58–62
Moore RD, Lietman PS, Smith CR (1987) Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis 155:93–99
Vogelman BS, Craig WA (1986) Postantibiotic effects. J Antimicrob Chemother 18:67–73
Craig WA, Vogelman BS (1987) The postantibiotic effect. Ann Intern Med 106:900–902
Hessen MT, Pitsakis PG, Levison ME (1989) Postantibiotic effect of penicillin plus gentamicin versusenterococcus faecalis in vitro and in vivo. Antimicrob Agents Chemother 33:608–611
Sturm AW (1989) Netilmicin in the treatment of Gram-negative Bacteremia: single daily versus multiple daily dosage. J Infect Dis 159:931–937
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Triginer, C., Izquierdo, I., Fernández, R. et al. Gentamicin volume of distribution in critically ill septic patients. Intensive Care Med 16, 303–306 (1990). https://doi.org/10.1007/BF01706354
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01706354